age related macular degeneration
Information
- Disease name
- age related macular degeneration
- Disease ID
- DOID:10871
- Description
- "A degeneration of macula and posterior pole that is characterized by a loss of vision in the center of the visual field (the macula) resulting from damage to the retina and resulting in blurring of the sharp central vision." [url:http\://en.wikipedia.org/wiki/Macular_degeneration]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05698316 | Active, not recruiting | A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression | May 4, 2023 | April 30, 2025 | |
| NCT04740671 | Active, not recruiting | Phase 3 | A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMD | July 1, 2021 | March 31, 2025 |
| NCT02438111 | Active, not recruiting | The Role of the Gut Metagenome on the Development of Age Related Macular Degeneration (AMD) | December 2013 | December 2023 | |
| NCT03845582 | Active, not recruiting | Phase 3 | Phase 3 Study of ALK-001 in Geographic Atrophy | May 7, 2019 | April 1, 2024 |
| NCT00358345 | Completed | PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization | October 2003 | September 2007 | |
| NCT00359008 | Completed | PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV) | July 2006 | September 2007 | |
| NCT00376701 | Completed | Phase 2 | Combination Therapy for Age-Related Macular Degeneration. | September 2006 | April 2009 |
| NCT00390208 | Completed | Phase 2 | Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration | August 2006 | December 2009 |
| NCT00413829 | Completed | Phase 2 | Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB) | October 2006 | March 2008 |
| NCT00446654 | Completed | Phase 1 | Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD | April 2007 | October 2007 |
| NCT00556348 | Completed | Phase 4 | Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration | November 2005 | November 2008 |
| NCT00902408 | Completed | N/A | Effect of Lutein-enriched-egg Beverage on Age-Related Macular Degeneration (AMD) | July 2009 | December 2011 |
| NCT00277784 | Completed | High-Resolution Ultrasound Imaging of the Retina and Choroid for Detection on Age Related Macular Degeneration | July 2005 | June 2006 | |
| NCT00331435 | Completed | Phase 4 | PDT Study for Exudative AMD With PCV | June 2006 | January 2010 |
| NCT00331864 | Completed | Phase 3 | SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration | April 2006 | April 2008 |
| NCT01170767 | Completed | Phase 3 | French Evaluation Group Avastin Versus Lucentis | June 2009 | December 2012 |
| NCT01243645 | Completed | N/A | MP-1 Biofeedback: Pattern Stimulus Versus Audio-feedback in AMD | ||
| NCT01272076 | Completed | Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE) | January 2011 | February 2011 | |
| NCT01301443 | Completed | Phase 1 | Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD) | February 2011 | May 2015 |
| NCT01327222 | Completed | Phase 3 | Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD) | February 2011 | February 2011 |
| NCT01334294 | Completed | Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular Degeneration | April 2011 | March 2014 | |
| NCT01363570 | Completed | N/A | Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes | January 2012 | October 2014 |
| NCT01453920 | Completed | Phase 4 | Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab Dosing | November 2011 | July 2012 |
| NCT01543568 | Completed | Phase 4 | Study for Recalcitrant Age Related Macular Degeneration | February 2012 | October 2014 |
| NCT01570608 | Completed | Phase 3 | Lucentis KAV Study | March 2007 | August 2011 |
| NCT01581606 | Completed | Evaluation of TeleOphthalmology in AMD-TeleMedicine Solutions to Improve Patient Access and Quality of Vision Outcomes | April 30, 2013 | April 7, 2014 | |
| NCT01632527 | Completed | Phase 1/Phase 2 | Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD) | June 2012 | June 2015 |
| NCT01634841 | Completed | N/A | Walnuts and Healthy Aging | April 2012 | May 2016 |
| NCT01644513 | Completed | Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients | July 2012 | December 2012 | |
| NCT01715870 | Completed | Life Style and Food Habits Questionnaire in the Portuguese Population Aged 55 or More | December 2012 | April 2014 | |
| NCT01822873 | Completed | Study on Visual Function Impairments in Dry Age-related Macular Degeneration | March 2013 | July 2018 | |
| NCT01846351 | Completed | Intravitreal Anti-VEGF in Exudative AMD With Epiretinal Membranes | July 2006 | February 2010 | |
| NCT01880788 | Completed | Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD | November 2012 | August 2015 | |
| NCT01914159 | Completed | Phase 2 | Ranibizumab In Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration Study | February 2013 | March 2016 |
| NCT02055612 | Completed | Mobile Clinic - a Cross-sectional Epidemiological Survey | March 2013 | July 2013 | |
| NCT02140411 | Completed | Phase 4 | Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema. | April 25, 2015 | December 21, 2016 |
| NCT02173496 | Completed | Colour Contrast Sensitivity for the Early Detection of Wet Age-related Macular Degereration (CEDAR) | October 2014 | May 2017 | |
| NCT02174211 | Completed | N/A | A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy. | June 2014 | December 2020 |
| NCT02218177 | Completed | Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD | August 2014 | December 2016 | |
| NCT02227498 | Completed | N/A | Argus II Retinal Prosthesis System Dry AMD Feasibility Study Protocol | June 2015 | March 2020 |
| NCT02441816 | Completed | Phase 4 | VITAL - Individualising Therapy for Neovascular AMD With Aflibercept | November 2014 | January 26, 2018 |
| NCT02550002 | Completed | Comparison of Treatment rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen | December 2015 | August 2022 | |
| NCT02556723 | Completed | N/A | Intravitreal Injections of Ziv-aflibercept for Macular Diseases | September 2014 | September 2016 |
| NCT02567604 | Completed | Development of Core Outcomes for Age-related Macular Degeneration (AMD) Interventions- Caregivers' Perspective | October 2015 | September 2018 | |
| NCT02725762 | Completed | N/A | Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration | March 2016 | July 2018 |
| NCT02903576 | Completed | Phase 1/Phase 2 | Stem Cell Therapy for Outer Retinal Degenerations | August 2015 | June 2019 |
| NCT02909985 | Completed | N/A | Visual Activity Evoked by Infrared in Humans After Dark Adaptation | September 2015 | August 2016 |
| NCT03035461 | Completed | Patient's Feelings After Receiving a Diagnosis of Age-related Macular Degeneration | March 15, 2017 | October 19, 2018 | |
| NCT03038048 | Completed | N/A | 30g vs 33g Needle for Intravitreal Injections | January 27, 2017 | April 27, 2017 |
| NCT03117634 | Completed | Phase 4 | An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy | December 1, 2017 | January 31, 2021 |
| NCT03222362 | Completed | Pars Plana Vitrecromy in Patients Aged 85 Years and Above | January 1, 2006 | December 31, 2015 | |
| NCT03278587 | Completed | N/A | Village-Integrated Eye Worker Trial II - Pilot | May 31, 2018 | March 1, 2020 |
| NCT03313401 | Completed | Effect of Aflibercept on Human Corneal Endothelial Cells in Neovascular Age-Related Macular Degeneration | January 2017 | June 2017 | |
| NCT03326401 | Completed | The Potential Role of Dietary Antioxidant Capacity on Age-Related Macular Degeneration | July 1, 2015 | February 20, 2016 | |
| NCT03393767 | Completed | Phase 4 | Time Course of Activity Signs at SD-OCT High Frequency Intravitreal Ranibizumab Treatment in CNV Due to AMD | December 2010 | December 2016 |
| NCT03409250 | Completed | Phase 4 | SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia | June 2011 | July 2014 |
| NCT03415984 | Completed | Prevalence of Age Related Macular Degeneration (ARMD) in Parkinson's Patients and Assesment of the Role of L-DOPA | January 19, 2018 | January 15, 2019 | |
| NCT03504540 | Completed | Comparison of Complement Factors and Genetic Polymorphisms of AMD Between Patients With Systemic Lupus Erythematosus (SLE) With and Without Retinal "Pseudo-drusen-like" Deposits: Case-control Study (PL-AMD) | April 5, 2018 | May 15, 2021 | |
| NCT03630562 | Completed | N/A | Assay of Pro-angiogenic Cytokines in Exudative Age-Related Macular Degeneration | November 26, 2018 | August 19, 2021 |
| NCT03927430 | Completed | Surgical Outcome of Macular Membrane Peeling Associated With Significant Macular Drusen | January 1, 2019 | March 1, 2019 | |
| NCT04169802 | Completed | Study Evaluating Retinal Health Monitoring System Visual Acuity Module. | November 20, 2019 | April 15, 2020 | |
| NCT04187157 | Completed | Association Between Light Spectrum and Survival After Cataract Surgery | January 1, 2012 | April 30, 2019 | |
| NCT04395859 | Completed | Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents | May 27, 2020 | February 15, 2022 | |
| NCT04522999 | Completed | N/A | Study of Photobiomodulation Effect on Electroretinogram Outcomes in Dry Age-Related Macular Degeneration | August 20, 2020 | August 13, 2021 |
| NCT04590196 | Completed | Early Phase 1 | Effect of Oral Curcumin Supplementation in Dry Age-related Macular Degeneration (AMD) Patients | November 1, 2020 | June 1, 2023 |
| NCT04689789 | Completed | OCTA and Retinal Angiomatous Proliferation | September 1, 2019 | December 20, 2020 | |
| NCT04761341 | Completed | Phase 4 | FLIO and the Influence of Oral Lutein Supplementation on Macular Pigment | June 1, 2018 | October 22, 2019 |
| NCT04778436 | Completed | N/A | Macula Evolution in Patients With AMD Taking Oral Food Supplementation | January 13, 2021 | January 24, 2022 |
| NCT04779398 | Completed | Association of MPOD Values With Blue Light. | September 25, 2020 | March 31, 2022 | |
| NCT04779411 | Completed | Online Validation of Dietary Intake Food Frequency Questionnaire Over Four Weeks, and Electronic Device Use Questionnaire Over Eight Weeks. | August 18, 2020 | October 1, 2022 | |
| NCT04895293 | Completed | Phase 1/Phase 2 | RBM-007 in Treatment naïve Exudative Age-related Macular Degeneration | June 15, 2021 | March 4, 2022 |
| NCT04920071 | Completed | Optimising Visual Acuity Measurement in Macular Degeneration | July 25, 2019 | May 31, 2023 | |
| NCT04993352 | Completed | Phase 1/Phase 2 | Evaluate the Safety and Efficacy of HLX04-O in Subjects With wAMD | July 15, 2021 | March 13, 2023 |
| NCT05287269 | Completed | Ocular Coherence Tomography During Cataract Assessment | November 2, 2020 | November 30, 2020 | |
| NCT00564902 | Completed | N/A | The Zeaxanthin and Visual Function Study | November 2007 | June 2009 |
| NCT00569569 | Completed | Phase 2/Phase 3 | Retaane® in Age-Related Macular Degeneration | February 2006 | March 2007 |
| NCT00592826 | Completed | HMP (Home Macular Perimeter) -Usability Trial | November 2007 | January 2008 | |
| NCT00593450 | Completed | Phase 3 | Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial | February 2008 | April 2015 |
| NCT00595998 | Completed | Sensitivity and Specificity of the Home Macular Perimeter (HMP) | January 2008 | November 2008 | |
| NCT00596388 | Completed | Usage of the Home Macular Perimeter (HMP) | March 2008 | March 2013 | |
| NCT00603850 | Completed | Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP) | January 2008 | April 2008 | |
| NCT00604071 | Completed | Sensitivity of the Home Macular Perimeter (HMP) | November 2007 | November 2008 | |
| NCT00605423 | Completed | Phase 2 | The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot | January 2008 | November 2011 |
| NCT00692887 | Completed | Correlation Between Visual Field Defects on Foresee Preferential Hyperacuity Perimeter(PHP) and on Optical Coherence Tomography (OCT) in Patients With Choroidal Neovascularization (CNV) | June 2008 | January 2009 | |
| NCT00713518 | Completed | Phase 2 | Phase II Open Label Multicenter Study For Age Related Macular Degeneration Comparing PF-04523655 Versus Lucentis In The Treatment Of Subjects With CNV (MONET Study). | November 2009 | July 2011 |
| NCT00729846 | Completed | Phase 2 | Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT) | May 2006 | July 2009 |
| NCT00734487 | Completed | AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study | June 2008 | August 2015 | |
| NCT00748384 | Completed | Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients | February 2009 | May 2013 | |
| NCT00776451 | Completed | Usability of the PreView PHP for Home Use in Intermediate AMD Patients | November 2008 | March 2009 | |
| NCT00776763 | Completed | Phase 2 | Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab | October 2008 | December 2010 |
| NCT00791570 | Completed | Phase 1 | Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy | October 2008 | April 2012 |
| NCT00800995 | Completed | Phase 3 | Superoxide Dismutase (SOD) as Antioxidant Treatment OF Age Related Macular Degeneration (ARMD) | September 2005 | June 2008 |
| NCT00826371 | Completed | Phase 3 | Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients | January 2009 | |
| NCT00864838 | Completed | Phase 2 | Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab | June 2008 | March 2009 |
| NCT00884637 | Completed | Correlation Between Visual Field Defects on FORESEE HOME and on Optical Coherence Tomography in Choroidal Neovascularization Subjects | June 2009 | March 2014 | |
| NCT00275821 | Completed | Phase 3 | Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) | December 2005 | January 2008 |
| NCT00931489 | Completed | Phase 2 | Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD) | August 2009 | June 2014 |
| NCT00963339 | Completed | Age-Related Macular Degeneration (AMD) - Usability Study | September 2009 | September 2010 | |
| NCT00992563 | Completed | Phase 2 | WALTZ - Wet Age-Related Macular Degeneration (AMD) AL-39324 Treatment Examination | June 2010 | May 2011 |
| NCT01010997 | Completed | Foresee Home for Monitoring Age Related Macular Degeneration (AMD) | December 2009 | January 2012 | |
| NCT01073592 | Completed | Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV) | August 2009 | March 2013 | |
| NCT01103505 | Completed | N/A | HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device | May 2010 | December 2013 |
| NCT01115556 | Completed | Phase 1/Phase 2 | A Pilot Study to Evaluate the Role of High-dose Ranibizumab (2.0mg) in the Management of AMD in Patients With Persistent/Recurrent Macular Fluid Less Than 30 Days Following Treatment With Intravitreal Anti-VEGF Therapy (the LAST Study) | May 2010 | January 2012 |
| NCT03076697 | Enrolling by invitation | Smartphone Screening for Eye Diseases | April 16, 2015 | August 30, 2028 | |
| NCT04794907 | Not yet recruiting | Retinal Care Data Repository | December 31, 2022 | December 2030 | |
| NCT03102138 | Not yet recruiting | Retinal Pigment Epithelium Safety Study For Patients In B4711001 | January 21, 2024 | May 30, 2033 | |
| NCT02521142 | Recruiting | Non-invasive Optical Angiography in Age-related Macular Degeneration | November 2015 | December 2023 | |
| NCT03963817 | Recruiting | Snapshot Camera for AMD | September 6, 2023 | February 2024 | |
| NCT04739319 | Recruiting | Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression | February 2, 2021 | November 2040 | |
| NCT04005443 | Recruiting | N/A | Molecular Imaging Exploration of Ocular Angiogenic Activity and Evaluation of Its Interest in the Therapeutic Follow-up of Patients With AMD (Age-related Macular Degeneration) | October 2, 2022 | December 30, 2024 |
| NCT02669953 | Recruiting | Aflibercept in Recurrent or Persistent CNV | December 2015 | December 2023 | |
| NCT01691261 | Recruiting | Phase 1 | A Study Of Implantation Of Retinal Pigment Epithelium In Subjects With Acute Wet Age Related Macular Degeneration | October 14, 2021 | March 14, 2024 |
| NCT04697095 | Recruiting | N/A | Survival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants | June 1, 2022 | December 2, 2024 |
| NCT04929756 | Recruiting | Eye Movement Rehabilitation in Low Vision Patients | September 4, 2020 | January 31, 2024 | |
| NCT03451500 | Terminated | Phase 2 | Carbidopa-Levodopa in Dry AMD With Geographic Atrophy | July 1, 2018 | October 31, 2019 |
| NCT01025232 | Terminated | Phase 1/Phase 2 | A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial) | December 2009 | January 2013 |
| NCT03275753 | Terminated | Visual Function Tests in Age-related Macular Degeneration | September 21, 2017 | December 31, 2022 | |
| NCT00347399 | Terminated | Phase 2 | Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration | March 2006 | June 30, 2007 |
| NCT00406744 | Terminated | Phase 3 | Efficacy of Retreatments With Intravitreal Bevacizumab | May 2006 | November 2006 |
| NCT04468373 | Terminated | N/A | Study of WA-NG (NG-IMT) Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration | May 2015 | July 2020 |
| NCT00993330 | Terminated | Macular Pigment Optical Density in Healthy Subjects | May 2009 | December 2010 | |
| NCT00347165 | Terminated | Phase 2 | Intravitreal Bevacizumab for Age-Related Macular Degeneration | September 2005 | September 2006 |
| NCT02002377 | Terminated | Phase 4 | Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections | April 17, 2014 | February 21, 2017 |
| NCT01255774 | Unknown status | Phase 3 | Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy | June 2007 | December 2012 |
| NCT01541449 | Unknown status | Plaqenil Role in Prevention of Age Related Macular Degeneration | January 2012 | April 2012 | |
| NCT01657669 | Unknown status | Phase 4 | Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term Results | October 2012 | December 2017 |
| NCT01670162 | Unknown status | Phase 4 | On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD) | August 2012 | January 2016 |
| NCT04572698 | Unknown status | Phase 3 | A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD） | November 2020 | December 2023 |
| NCT01943396 | Unknown status | Phase 4 | Treatment of AMD With Rheohemapheresis /RHF/ | September 2013 | September 2016 |
| NCT00710229 | Unknown status | Phase 3 | Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration | July 2008 | |
| NCT02016508 | Unknown status | Phase 1/Phase 2 | Safety Study of Use of Autologous Bone Marrow Derived Stem Cell in Treatment of Age Related Macular Degeneration | March 2013 | June 2015 |
| NCT04863391 | Unknown status | Telemedicine in Age-Related Macular Degeneration | July 19, 2020 | December 31, 2022 | |
| NCT02173873 | Unknown status | Phase 1 | Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase I | June 2014 | December 2016 |
| NCT03609307 | Unknown status | Phase 2/Phase 3 | Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial | September 2018 | February 2019 |
| NCT00809419 | Unknown status | Phase 1/Phase 2 | A Study of the NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy | November 2008 | November 2012 |
| NCT02296567 | Unknown status | Phase 2/Phase 3 | Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients | December 2014 | July 2016 |
| NCT03750149 | Unknown status | N/A | Reading Analysis in Ophthalmologic Patients | January 1, 2018 | January 1, 2021 |
| NCT03760055 | Unknown status | Assessment of Visual Function With a Portable Brain-computer Interface | February 11, 2019 | January 2024 | |
| NCT03772938 | Unknown status | Phase 1 | Stem Cells Therapy in Degenerative Diseases of the Retina | December 13, 2018 | March 31, 2020 |
| NCT03823092 | Unknown status | Polarization Perception in Health and Disease. Testing a New Sight Test | November 9, 2017 | July 2019 | |
| NCT01014468 | Unknown status | Phase 3 | Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration | March 2009 | February 2012 |
| NCT01023971 | Unknown status | Macular Function During Anti-VEGF Treatment | January 2009 | ||
| NCT02681783 | Unknown status | Phase 4 | PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept | December 1, 2018 | December 1, 2022 |
| NCT02868424 | Unknown status | Early Phase 1 | Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation | February 13, 2016 | December 2018 |
| NCT05003245 | Unknown status | Phase 3 | Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMD | November 1, 2021 | March 31, 2024 |
| NCT01348672 | Unknown status | Prospective Study Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye | March 2012 | August 2015 | |
| NCT03056079 | Unknown status | Phase 4 | Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept | February 28, 2017 | February 28, 2024 |
| NCT03056092 | Unknown status | Phase 4 | Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab | February 28, 2017 | February 28, 2024 |
| NCT01516294 | Unknown status | N/A | IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD | January 2012 | March 2014 |
| NCT01521819 | Unknown status | N/A | Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration | August 2012 | August 2014 |
| NCT05005884 | Unknown status | Phase 1 | Possible Effects of Supplement Therapy With Oral Phenolics on Cluster of Differentiation 163 (CD-163) Biomarker of Patients With Age-related Macular Degeneration | July 28, 2021 | December 1, 2022 |
| NCT01626339 | Unknown status | N/A | Effect of Intravitreal Anti-VEGF on Retinal Vessels Diameter | April 2012 | |
| NCT03205202 | Unknown status | Phase 4 | Cataract and AMD in a Trial of a Multivitamin and Cocoa Extract | June 1, 2015 | October 2022 |
| NCT00457678 | Withdrawn | Phase 2 | Second Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself | January 2007 | December 4, 2007 |
| NCT04334499 | Withdrawn | Mitochondrial DNA in Vitreous Fluid and Blood in Patients With Eye Disease or Ocular Trauma. | February 21, 2020 | December 7, 2022 | |
| NCT03046485 | Withdrawn | N/A | Use of Self-management Group to Improve Quality of Life in Patients With Low Vision | May 2007 | December 2016 |
| NCT01336907 | Withdrawn | Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV) | |||
| NCT00557791 | Withdrawn | Phase 3 | Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON) | November 2009 | July 2012 |
| NCT01361256 | Withdrawn | Early Phase 1 | Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration | May 2011 | May 2016 |
| NCT03446144 | Withdrawn | Phase 2 | Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) | March 16, 2018 | October 10, 2018 |
| NCT00726466 | Withdrawn | Phase 1 | Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration | March 2008 | |
| NCT01731964 | Withdrawn | N/A | Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration | November 2012 | December 2015 |
- Disase is a (Disease Ontology)
- DOID:2007
- Cross Reference ID (Disease Ontology)
- EFO:0001365
- Cross Reference ID (Disease Ontology)
- ICD10CM:H35.30
- Cross Reference ID (Disease Ontology)
- ICD9CM:362.50
- Cross Reference ID (Disease Ontology)
- MESH:D008268
- Cross Reference ID (Disease Ontology)
- MIM:PS603075
- Cross Reference ID (Disease Ontology)
- NCI:C84391
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:18222007
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0242383
- Exact Synonym (Disease Ontology)
- Age Related Maculopathies
- Exact Synonym (Disease Ontology)
- Age Related Maculopathy
- Exact Synonym (Disease Ontology)
- age-related macular degeneration
- Exact Synonym (Disease Ontology)
- Senile macular degeneration
- Exact Synonym (Disease Ontology)
- Senile macular retinal degeneration